Breast Cancer is usually classified in relation to biomarkers expressed by the tumor. The presence of estrogen and progesterone receptor or over-expression of EGFR – Erb B2 – make possible to distinguish tumors as ER-positive, Erb B2 positive or triple negative. In addition to this classification, Breast Cancer may be localized or spread in metastases. […]